These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11197335)

  • 1. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
    Stauffer SR; Huang YR; Aron ZD; Coletta CJ; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):151-61. PubMed ID: 11197335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor.
    Stauffer SR; Huang Y; Coletta CJ; Tedesco R; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):141-50. PubMed ID: 11197334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
    Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonists selective for estrogen receptor alpha.
    Sun J; Huang YR; Harrington WR; Sheng S; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2002 Mar; 143(3):941-7. PubMed ID: 11861516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
    Minutolo F; Antonello M; Bertini S; Rapposelli S; Rossello A; Sheng S; Carlson KE; Katzenellenbogen JA; Macchia M
    Bioorg Med Chem; 2003 Apr; 11(7):1247-57. PubMed ID: 12628652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential estrogen receptor subtype modulators: assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles.
    Alexi X; Kasiotis KM; Fokialakis N; Lambrinidis G; Meligova AK; Mikros E; Haroutounian SA; Alexis MN
    J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):159-67. PubMed ID: 19772920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.
    Fink BE; Mortensen DS; Stauffer SR; Aron ZD; Katzenellenbogen JA
    Chem Biol; 1999 Apr; 6(4):205-19. PubMed ID: 10099132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
    Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
    Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of tetrasubstituted pyrazoles, novel ligands for the estrogen receptor.
    Stauffer SR; Katzenellenbogen JA
    J Comb Chem; 2000; 2(4):318-29. PubMed ID: 10891098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists.
    Lloyd DG; Smith HM; O'Sullivan T; Knox AS; Zisterer DM; Meegan MJ
    Med Chem; 2006 Mar; 2(2):147-68. PubMed ID: 16787364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens.
    Ekena K; Weis KE; Katzenellenbogen JA; Katzenellenbogen BS
    J Biol Chem; 1997 Feb; 272(8):5069-75. PubMed ID: 9030571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel nitro-substituted triaryl pyrazole derivatives as potential estrogen receptor ligands.
    Naoum F; Kasiotis KM; Magiatis P; Haroutounian SA
    Molecules; 2007 Jul; 12(7):1259-73. PubMed ID: 17909483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.